View in EDS

Can iodixAnol ReducE the incidence of adverse renal or cardiac events in chronic total occlusion interventions (CARE-CTO): a substudy of the PROGRESS-CTO registry.

Saved in:
Bibliographic Details
Title: Can iodixAnol ReducE the incidence of adverse renal or cardiac events in chronic total occlusion interventions (CARE-CTO): a substudy of the PROGRESS-CTO registry.
Authors: Strepkos D; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota., Rempakos A; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota., Alexandrou M; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota., Mutlu D; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota., Carvalho PEP; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota., Ser OS; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota., Alaswad K; Henry Ford Cardiovascular Division, Detroit, Michigan., Basir MB; Henry Ford Cardiovascular Division, Detroit, Michigan., Khelimskii D; Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia., Krestyaninov O; Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia., Khatri JJ; Cleveland Clinic, Cleveland, Ohio., Young L; Cleveland Clinic, Cleveland, Ohio., Goktekin O; Memorial Bahcelievler Hospital, Istanbul, Turkey., Poommipanit P; University Hospitals, Case Western Reserve University, Cleveland, Ohio., Jaffer F; Massachusetts General Hospital, Boston, Massachusetts., Gorgulu S; Biruni University Medical School, Istanbul, Turkey., ElGuindy AM; Aswan Heart Center, Aswan, Egypt., Abi Rafeh N; North Oaks Health System, Hammond, Louisiana., Mastrodemos O; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota., Rangan BV; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota., Jalli S; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota., Voudris K; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota., Sandoval Y; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota., Burke MN; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota., Brilakis ES; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota. Email: esbrilakis@gmail.com.
Source: The Journal of invasive cardiology [J Invasive Cardiol] 2025 Sep; Vol. 37 (9).
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: HMP Communications Country of Publication: United States NLM ID: 8917477 Publication Model: Print Cited Medium: Internet ISSN: 1557-2501 (Electronic) Linking ISSN: 10423931 NLM ISO Abbreviation: J Invasive Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-2501
DOI:10.25270/jic/25.00004